| Masthead |
|
|
|
|
|
|
|
|
|
| Erratum |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| A novelnull mutation in the rhodopsin gene causing late onset autosomal dominant retinitis pigmentosa |
|
|
|
|
|
|
|
|
|
| A novel mutation in exon 12 (Y569C) of the CFTR gene identified in a patient of croatian origin |
|
|
|
|
|
|
✓ |
|
croatian origin |
| Identification of a 4 bp deletion (1560de14) in Po gene in a family with severe charcot-Marie-Tooth disease |
|
|
|
|
|
|
|
|
|
| Two New Nonsense mutations (Q80X; Q389X) in patients with severe hunter syndrome ( mucopolysaccharidosis type II) |
|
|
|
|
|
|
|
|
|
| Announcement |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| A 66-Basepair insertion in Exon 6 of the α-L-fucosidase gene of a fucosidosis patient; |
|
|
|
|
|
|
|
|
|
| Announcement |
|
|
|
|
|
|
|
|
|
| A novel nonsense mutation,S466Xa in exon 10 of the cystic fibrosis transmembrane conductance regulator gene |
|
|
|
|
|
|
|
|
|
| Frameshift mutation at codon 642 of thehMLH1 gene in human endometrial cancer |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Mutations and Polymorphisms in the familial early-onset breast cancer (BRCA1) gene |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Erratum |
|
|
|
|
|
|
|
|
|
| Editorial |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Identification of a novel R552Q mutation in exon 13 of the β-subunit of rod phosphodiesterase gene in a Spanish family with autosomal recessive retinitis pigmentosa |
|
|
|
|
|
|
✓ |
|
Spanish family |
| A novel mutation (S558X) causing choroideremia |
|
|
|
|
|
|
|
|
|
| Erratum |
|
|
|
|
|
|
|
|
|
| Announcement |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Update on nomenclature for human gene mutations |
|
|
|
|
|
|
|
|
|
| Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient |
|
|
|
|
|
|
|
|
|
| Identification of a novel single base insertion in the adenomatous polyposis coli gene |
|
|
|
|
|
|
|
|
|
| Advantages of RT-PCR and denaturing gradient gel electrophoresis for analysis of genomic imprinting: Detection of new mouse and human expressed polymorphisms |
|
|
|
|
|
|
|
|
|
| Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure |
|
|
|
|
|
|
|
|
|
| A novel splice-site mutation in the CD40L gene in a patient with X-linked hyper-IgM syndrome |
|
|
|
|
|
|
|
|
|
| Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays |
|
|
|
|
|
|
|
|
|
| Novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia c gene,FAC |
|
|
|
|
|
|
|
|
|
| A novel missense mutation in the exon containing the putative ornithine‐binding domain of the OTC enzyme in a female |
|
|
|
|
|
|
|
|
|
| A novel combination of mitochondrial tRNA and ND1 gene mutations in a syndrome with MELAS, cardiomyopathy, and diabetes mellitus |
|
|
|
|
|
|
|
|
|
| Identification of a donor splice site mutation leading to loss of p22‐
<i>phox</i>
exon 5 in autosomal chronic granulomatous disease |
|
|
|
|
|
|
|
|
|
| Single base-pair substitutions in pathology and evolution: Two sides to the same coin |
|
|
|
|
|
|
|
|
|
| A sensitive mutation screening strategy for Fabry disease: Detection of nine mutations in the α-galactosidase A gene |
|
|
|
|
|
|
|
|
|
| Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses ofRET proto-oncogene mutations |
|
|
|
|
|
|
|
|
|
| Clinically applicable mutation screening in familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Four novel germline mutations of the APC gene |
|
|
|
|
|
|
|
|
|
| Mutation analysis of phenylketonuria in South Brazil |
|
|
|
|
|
|
|
|
|
| Detection of new variants in the apolipoprotein B (Apo B) gene by PCR-SSCP |
|
|
|
|
|
|
|
|
|
| Identification of two new nonsense mutations Q311X and W326X in Exon 2 of the adrenoleukodystrophy (ALD) gene |
|
|
|
|
|
|
|
|
|
| A novel mutation in theBRCA1 gene in a German early-onset breast cancer family |
|
|
|
|
|
|
✓ |
|
German |
| Mutations in pyruvate kinase |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis type I: Identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations |
|
|
|
|
|
|
|
|
|
| Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome |
|
|
|
|
|
|
|
|
|
| Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease |
|
|
|
|
|
|
|
|
|
| Chimeric probe-mediated ribonuclease protection assay for molecular diagnosis of mRNA deficiencies |
|
|
|
|
|
|
|
|
|
| Identification of three novel mutations in the acid sphingomyelinase gene of Japanese patients with Niemann–Pick disease type A and B |
|
|
|
|
|
|
|
|
|
| A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects |
|
|
|
|
|
|
✓ |
|
Norwegian |
| Nonsense mutations in a Becker muscular dystrophy and an intermediate patient |
|
|
|
|
|
|
|
|
|
| Mutation analysis in 20 patients with Hunter disease |
|
|
|
|
|
|
|
|
|
| New point mutation (R243W) in the hormone binding domain of the c-erbA β1 gene in a family with generalized resistance to thyroid hormone |
|
|
|
|
|
|
|
|
|
| Characterization of a partial pseudogene homologous to the adrenoleukodystrophy gene and application to mutation detection |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of n-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease |
|
|
|
|
|
|
|
|
|
| Mass allele detection (MAD) of rare 5-HT1A structural variants with allele-specific amplification and electrochemiluminescent detection |
|
|
|
|
|
|
|
|
|
| Substitution of A1498D in noncollagen domain of a5(IV) collagen chain associated with adult-onset X-linked alport syndrome |
|
|
|
|
|
|
|
|
|
| A newly identified aldolase B splicing mutation (G→C, 5′ intron 5) in hereditary fructose intolerance from New Zealand |
|
|
|
|
|
|
|
|
|
| Identification of a mutation in the mitochondrial tRNACys gene associated with mitochondrial encephalopathy |
|
|
|
|
|
|
|
|
|
| Novel mutations in the connexin 32 gene associated with X-linked Charcot-Marie tooth disease |
|
|
|
|
|
|
|
|
|
| Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| Two novel (R(−11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds |
|
|
|
|
|
|
|
|
|
| Missense mutation A346P in the rhodopsin gene in one family with autosomal dominant retinitis pigmentosa |
|
|
|
|
|
|
|
|
|
| A novel missense mutation in exon 16 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in CBAVD patients |
|
|
|
|
|
|
|
|
|
| A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene |
|
|
|
|
|
|
|
|
|
| Deletion analysis of the simple tandem repeat loci physically linked to the spinal muscular atrophy locus |
|
|
|
|
|
|
|
|
|
| Splice site mutation causing deletion of exon 21 sequences from the proα2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme |
|
|
|
|
|
|
|
|
|
| Fumarylacetoacetase mutations in tyrosinaemia type I |
|
|
|
|
|
|
|
|
|
| A 5-megabase familial deletion removes the IDS and FMR-1 genes in a male Hunter patient |
|
|
|
|
|
|
|
|
|
| Two point mutations (313 + 1G→A and 313 + 1G→T) in the splice donor site of intron 3 of the low-density lipoprotein receptor gene are associated with familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Somatic mutations of a human mismatch repair gene, hMLH1, in tumors from patients with multiple primary cancers |
|
|
|
|
|
|
|
|
|
| CDKN2A (p16INK4A) somatic and germline mutations |
|
|
|
|
|
|
|
|
|
| Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR |
|
|
|
|
|
|
|
|
|
| Characterization of two arylsulfatase A missense mutations D335V and T274M causing late infantile metachromatic leukodystrophy |
|
|
|
|
|
|
|
|
|
| Mutation in the carboxy-terminal propeptide of the proα1 (I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): Possible implications for protein folding |
|
|
|
|
|
|
|
|
|
| Mutation of thehMSH2 gene in two families with hereditary nonpolyposis colorectal cancer |
|
|
|
|
|
|
|
|
|
| Mutations in the BRCA1 gene in Japanese breast cancer patients |
|
|
|
|
|
|
|
|
|
| Mutation detection by solid phase primer extension |
|
|
|
|
|
|
|
|
|
| Two novel frameshift mutations causing premature stop codons in a patient with the severe form of Maroteaux-Lamy syndrome |
|
|
|
|
|
|
|
|
|
| Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I |
|
|
|
|
|
|
|
|
|
| A donor splice site mutation (1811+1G→C) in intron 11 of the CFTR gene identified in a patient of Macedonian origin |
|
|
|
|
|
|
✓ |
|
patient of Macedonian origin |
| Identification of a novel PAX6 gene mutation in an Aniridia patient |
|
|
|
|
|
|
|
|
|
| DGGE analysis as supplement to SSCP analysis of the phenylalanine hydroxylase gene: Detection of eight (one de novo, seven inherited) of nine remaining Norwegian PKU mutations |
|
|
|
|
|
|
|
|
|
| Repeat offenders: Simple repeat sequences and complex genetic problems |
|
|
|
|
|
|
|
|
|
| Somatic stability of the expanded CAG trinucleotide repeat in X-linked spinal and bulbar muscular atrophy |
|
|
|
|
|
|
|
|
|
| IDS gene-pseudogene exchange responsible for an intragenic deletion in a hunter patient |
|
|
|
|
|
|
|
|
|
| Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome |
|
|
|
|
|
|
|
|
|
| Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland |
|
|
|
|
|
|
|
|
|
| Recurrence of thePROC gene mutation R178Q: Independent origins in Spanish protein C deficiency patients |
|
|
|
|
|
|
✓ |
|
Spanish |
| Novel missense mutation of the connexin32 (GJB1) gene in X-linked dominant charcot-marie-tooth neuropathy |
|
|
|
|
|
|
|
|
|
| Novel and unusual deletion-insertion thalassemic mutation in exon 1 of the β-globin gene |
|
|
|
|
|
|
|
|
|
| New mutation in the 3′-acceptor splice site of intron 4 in the rhodopsin gene associated with autosomal dominant retinitis pigmentosa in a Basque family |
|
|
|
|
|
|
✓ |
|
Basque family |
| Mutation pattern in clinically asymptomatic coagulation factor VII deficiency |
|
|
|
|
|
|
|
|
|
| Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews |
|
|
|
|
|
|
|
|
|
| Allele-specific measurement of low-density lipoprotein receptor transcript levels |
|
|
|
|
|
|
|
|
|
| Complex cystic fibrosis allele R334W-R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient |
|
|
|
|
|
|
|
|
|
| Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphicCFTR DNA markers |
|
|
|
|
|
|
|
|
|
| Comprehensive and accurate mutation scanning of theCFTR gene by two-dimensional DNA electrophoresis |
|
|
|
|
|
|
|
|
|
| Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia |
|
|
|
|
|
|
|
|
|
| Three new mutations of the pyruvate dehydrogenase alpha subunit: A point mutation (M181V), 3 bp deletion (-R282), and 16 bp insertion/frameshift (K358SVS→TVDQS) |
|
|
|
|
|
|
|
|
|
| New frameshift mutation in theDAX-1 gene in a patient with X-linked adrenal hypoplasia and hypogonadotropic hypogonadism |
|
|
|
|
|
|
|
|
|
| Charcot-Marie-Tooth type 1B neuropathy: A mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0 |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis IVA (Morquio A): Three novel small deletions in the N-acetylgalactosamine-6-sulfate sulfatase gene |
|
|
|
|
|
|
|
|
|
| Two new variants of RAG-1 protein predicted by SSCP |
|
|
|
|
|
|
|
|
|
| Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis |
|
|
|
|
|
|
|
|
|
| Glucocerebrosidase (Gaucher disease) |
|
|
|
|
|
|
|
|
|
| Identification and application of polymorphisms flanking the human adenine phosphoribosyltransferase gene |
|
|
|
|
|
|
|
|
|
| An additional mitochondrial tRNAIle point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy |
|
|
|
|
|
|
|
|
|
| Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome |
|
|
|
|
|
|
|
|
|
| Fluorescent multiplex microsatellites used to define haplotypes associated with 75 CFTR mutations from the UK on 437 CF chromosomes |
|
|
|
|
|
|
|
|
|
| PKU mutation (D143G) associated with an apparent high residual enzyme activity: Expression of a kinetic variant form of phenylalanine hydroxylase in three different systems |
|
|
|
|
|
|
|
|
|
| Rapid molecular diagnosis of mutations associated with generalized thyroid hormone resistance by PCR-coupled automated direct sequencing of genomic DNA: Detection of two novel mutations |
|
|
|
|
|
|
|
|
|
| Unequal homologous crossing over resulting in duplication of 36 base pairs within Exon 47 of the COL4A5 gene in a family with Alport syndrome |
|
|
|
|
|
|
|
|
|
| Novel missense mutation (W686C) of the phosphofructokinase‐M gene in a Japanese patient with a mild form of glycogenosis VII |
|
|
|
|
|
|
✓ |
|
Japanese patient |
| Phenylalanine hydroxylase deficiency in a population in Germany: Mutational profile and nine novel mutations |
|
|
|
|
|
|
|
|
|
| Type 1 Gaucher disease: Identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese |
|
|
|
|
|
|
|
|
|
| Mutations and polymorphisms in the human peripherin-RDS gene and their involvement in inherited retinal degeneration |
|
|
|
|
|
|
|
|
|
| A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Déjérine—Sottas syndrome patients |
|
|
|
|
|
|
|
|
|
| A novel deletion/inversion mutation in the low-density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Ornithine transcarbamylase deficiency: Characterization of gene mutations and polymorphisms |
|
|
|
|
|
|
|
|
|
| A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles |
|
|
|
|
|
|
|
|
|
| Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency |
|
|
|
|
|
|
|
|
|
| A 3‐base pair in‐frame deletion in exon 8 (delGlu272/273) of the ornithine transcarbamylase gene in late‐onset hyperammonemic coma |
|
|
|
|
|
|
|
|
|
| Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia |
|
|
|
|
|
|
|
|
|
| A novel mutation in exon 6 (F236S) of the proteolipid protein gene is associated with spastic paraplegia |
|
|
|
|
|
|
|
|
|
| A locus-specific mutation database for the neural cell adhesion molecule L1CAM (Xq28) |
|
|
|
|
|
|
|
|
|
| A common base change in the promoter region of the human endothelial NO-synthase (NQS3) gene |
|
|
|
|
|
|
|
|
|
| Three novel APC gene mutations in portuguese FAP kindreds |
|
|
|
|
|
|
|
|
|
| Identification of a novel mutation (A268G) in exon 8 of the HTRβ gene in a large family with thyroid hormone resistance |
|
|
|
|
|
|
|
|
|
| Mutation analysis of the pyruvate dehydrogenase E1α gene in eight patients with a pyruvate dehydrogenase complex deficiency |
|
|
|
|
|
|
|
|
|
| A novel G499D substitution in the α1(III) chain of type III collagen produces variable forms of Ehlers-Danlos syndrome type IV |
|
|
|
|
|
|
|
|
|
| Molecular genetics of human antithrombin deficiency |
|
|
|
|
|
|
|
|
|
| An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants |
|
|
|
|
|
|
|
|
|
| Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis |
|
|
|
|
|
|
|
|
|
| Detection ofRET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Molecular analysis of the TP53 gene in Barrett's adenocarcinoma |
|
|
|
|
|
|
|
|
|
| Rapid detection of point mutations and polymorphisms of the α-globin genes by DGGE and SSCA |
|
|
|
|
|
|
|
|
|
| A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty |
|
|
|
|
|
|
|
|
|
| Novel initiation codon mutation Met1Thr identified in a patient with partial hypoxanthine-guanine phosphoribosyl-transferase (HPRT) deficiency: HPRT Heidelberg |
|
|
|
|
|
|
|
|
|
| Identification of two sporadically derived mutations in the Von Hippel-Lindau gene |
|
|
|
|
|
|
|
|
|
| Direct sequencing of PCR products derived from cDNAs for the proα1 and proα2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| Molecular basis of congenital erythropoietic porphyria: Mutations in the human uroporphyrinogen III synthase gene |
|
|
|
|
|
|
|
|
|
| Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging |
|
|
|
|
|
|
|
|
|
| Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses |
|
|
|
|
|
|
|
|
|
| Gaucher disease: Identification of three new mutations in the Korean and Chinese (Taiwanese) populations |
|
|
|
|
|
|
✓ |
|
Korean and Chinese (Taiwanese) populations |
| Sensitive and fast mutation detection by solid phase chemical cleavage |
|
|
|
|
|
|
|
|
|
| Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the β‐glucocerebrosidase gene in Gaucher's disease patients |
|
|
|
|
|
|
|
|
|
| Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases |
|
|
|
|
|
|
|
|
|
| Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100 |
|
|
|
|
|
|
|
|
|
| Pelizaeus-Merzbacher disease: A novel mutation in the 5′-untranslated region of the proteolipid protein gene |
|
|
|
|
|
|
|
|
|
| Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African‐Americans |
|
|
|
|
|
|
|
|
|
| Identification of three novel mutations in the cystic fibrosis transmembrane conductance regulator gene in Argentinian CF patients |
|
|
|
|
|
|
|
|
|
| Simple detection of a (Finnish) hereditary tyrosinemia type 1 mutation |
|
|
|
|
|
|
✓ |
|
Finnish |
| Partial duplication [dup. TCAC (178)] and novel point mutations (T125M, G188R, A209V, and H302L) of the ornithine transcarbamylase gene in congenital hyperammonemia |
|
|
|
|
|
|
|
|
|
| A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency |
|
|
|
|
|
|
|
|
|
| Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene |
|
|
|
|
|
|
|
|
|
| Three novel and two recurrent mutations of the Norrie disease gene in patients with Norrie syndrome |
|
|
|
|
|
|
|
|
|
| Mutation nomenclature: Nicknames, systematic names, and unique identifiers |
|
|
|
|
|
|
|
|
|
| Ethnic difference in the pattern of K-ras oncogene mutations in human colorectal cancers |
|
|
|
|
|
|
|
|
|
| Two novel mutations (C53S, S26L) in the connexin32 of Charcot‐Marie‐Tooth disease type X families |
|
|
|
|
|
|
|
|
|
| A familial deletion in the Prader-Willi syndrome region including the imprinting control region |
|
|
|
|
|
|
|
|
|
| New frameshift mutation, insertion of A, at codon 95 of the β-globin gene causes β-thalassemia in two Vietnamese families |
|
|
|
|
|
|
|
|
|
| Independent origin of single and double mutations in the human glucose 6-phosphate dehydrogenase gene |
|
|
|
|
|
|
|
|
|
| Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity |
|
|
|
|
|
|
|
|
|
| Mutation characterization ofCFTR gene in 206 Northern Irish CF families: Thirty mutations, including two novel, account for 94% of CF chromosomes |
|
|
|
|
|
|
|
|
|
| Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan |
|
|
|
|
|
|
|
|
|
| Absence ofPMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for charcot-marie-tooth disease type 1A |
|
|
|
|
|
|
|
|
|
| Stop codon in exon 30 (E2069X) of β-spectrin gene associated with hereditary elliptocytosis in spectrin Nagoya |
|
|
|
|
|
|
|
|
|
| A point mutation in codon 3 of connexin‐32 is associated with X‐linked charcot‐marie‐tooth neuropathy |
|
|
|
|
|
|
|
|
|
| A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease |
|
|
|
|
|
|
|
|
|
| Crouzon syndrome: Previously unrecognized deletion, duplication, and point mutation within FGFR2 gene |
|
|
|
|
|
|
|
|
|
| A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia |
|
|
|
|
|
|
|
|
|
| Novel mutations and polymorphisms in the Fanconi anemia group C gene |
|
|
|
|
|
|
|
|
|
| Detection of new variants in the apolipoprotein B (Apo B) gene by PCR‐SSCP |
|
|
|
|
|
|
|
|
|
| Nonsense mutations in a Becker muscular dystrophy and an intermediate patient |
|
|
|
|
|
|
|
|
|
| New point mutation (R243W) in the hormone binding domain of the c‐erbA β1 gene in a family with generalized resistance to thyroid hormone |
|
|
|
|
|
|
|
|
|
| An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants |
|
|
|
|
|
|
|
|
|
| Recurrent 2‐bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis |
|
|
|
|
|
|
|
|
|
| Molecular analysis of the TP53 gene in Barrett's adenocarcinoma |
|
|
|
|
|
|
|
|
|
| Rapid detection of point mutations and polymorphisms of the α‐globin genes by DGGE and SSCA |
|
|
|
|
|
|
|
|
|
| Novel mutations in the connexin 32 gene associated with X‐linked Charcot‐Marie tooth disease |
|
|
|
|
|
|
|
|
|
| Two novel (R(−11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds |
|
|
|
|
|
|
|
|
|
| A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene |
|
|
|
|
|
|
|
|
|
| Direct sequencing of PCR products derived from cDNAs for the proα1 and proα2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| Cystic fibrosis mutation detection by hybridization to light‐generated DNA probe arrays |
|
|
|
|
|
|
|
|
|
| Novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia c gene, FAC |
|
|
|
|
|
|
|
|
|
| Somatic mutations of a human mismatch repair gene, hMLH1, in tumors from patients with multiple primary cancers |
|
|
|
|
|
|
|
|
|
| CDKN2A (p16INK4A) somatic and germline mutations |
|
|
|
|
|
|
|
|
|
| Mutations in the BRCA1 gene in Japanese breast cancer patients |
|
|
|
|
|
|
|
|
|
| Deletion of Gly723 in the insulin receptor substrate‐1 of a patient with noninsulin‐dependent diabetes mellitus |
|
|
|
|
|
|
|
|
|
| A donor splice site mutation (1811+1G→C) in intron 11 of the CFTR gene identified in a patient of Macedonian origin |
|
|
|
|
|
|
✓ |
|
Macedonian origin |
| Partial duplication [dup. TCAC (178)] and novel point mutations (T125M, G188R, A209V, and H302L) of the ornithine transcarbamylase gene in congenital hyperammonemia |
|
|
|
|
|
|
|
|
|
| A 14‐bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency |
|
|
|
|
|
|
|
|
|
| Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia |
|
|
|
|
|
|
|
|
|
| Two new variants of RAG‐1 protein predicted by SSCP |
|
|
|
|
|
|
|
|
|
| Two novel mutations (C53S, S26L) in the connexin32 of Charcot‐Marie‐Tooth disease type X families |
|
|
|
|
|
|
|
|
|
| Novel missense mutation (W686C) of the phosphofructokinase‐M gene in a Japanese patient with a mild form of glycogenosis VII |
|
|
|
|
|
|
✓ |
|
Japanese |
| Missense mutation in the paired domain of PAX3 causes craniofacial‐deafness‐hand syndrome |
|
|
|
|
|
|
|
|
|
| Clinically applicable mutation screening in familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Gaucher disease: Identification of three new mutations in the Korean and Chinese (Taiwanese) populations |
|
|
|
|
|
|
|
|
|
| Mutation analysis of the pyruvate dehydrogenase E1α gene in eight patients with a pyruvate dehydrogenase complex deficiency |
|
|
|
|
|
|
|
|
|
| Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X‐inactivation causing Lesch‐Nyhan syndrome in a female patient |
|
|
|
|
|
|
|
|
|
| Identification of three novel mutations in the acid sphingomyelinase gene of Japanese patients with Niemann‐Pick disease type A and B |
|
|
|
|
|
|
|
|
|
| Identification of a novel single base insertion in the adenomatous polyposis coli gene |
|
|
|
|
|
|
|
|
|
| Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Advantages of RT‐PCR and denaturing gradient gel electrophoresis for analysis of genomic imprinting: Detection of new mouse and human expressed polymorphisms |
|
|
|
|
|
|
|
|
|
| Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| A novel missense mutation in exon 16 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in CBAVD patients |
|
|
|
|
|
|
|
|
|
| Molecular basis of congenital erythropoietic porphyria: Mutations in the human uroporphyrinogen III synthase gene |
|
|
|
|
|
|
|
|
|
| Deletion analysis of the simple tandem repeat loci physically linked to the spinal muscular atrophy locus |
|
|
|
|
|
|
|
|
|
| Sensitive and fast mutation detection by solid phase chemical cleavage |
|
|
|
|
|
|
|
|
|
| Characterization of two arylsulfatase A missense mutations D335V and T274M causing late infantile metachromatic leukodystrophy |
|
|
|
|
|
|
|
|
|
| Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer |
|
|
|
|
|
|
|
|
|
| Two novel frameshift mutations causing premature stop codons in a patient with the severe form of Maroteaux‐Lamy syndrome |
|
|
|
|
|
|
|
|
|
| Identification of a novel PAX6 gene mutation in an Aniridia patient |
|
|
|
|
|
|
|
|
|
| Complete deficiency of plasma lecithin‐cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly‐30‐Ser) in the LCAT gene |
|
|
|
|
|
|
|
|
|
| Novel missense mutation of the connexin32 (GJB1) gene in X‐linked dominant charcot‐marie‐tooth neuropathy |
|
|
|
|
|
|
|
|
|
| Novel and unusual deletion‐insertion thalassemic mutation in exon 1 of the β‐globin gene |
|
|
|
|
|
|
|
|
|
| Mutation pattern in clinically asymptomatic coagulation factor VII deficiency |
|
|
|
|
|
|
|
|
|
| Identification and application of polymorphisms flanking the human adenine phosphoribosyltransferase gene |
|
|
|
|
|
|
|
|
|
| PKU mutation (D143G) associated with an apparent high residual enzyme activity: Expression of a kinetic variant form of phenylalanine hydroxylase in three different systems |
|
|
|
|
|
|
|
|
|
| A familial deletion in the Prader‐Willi syndrome region including the imprinting control region |
|
|
|
|
|
|
|
|
|
| New frameshift mutation, insertion of A, at codon 95 of the β‐globin gene causes β‐thalassemia in two Vietnamese families |
|
|
|
|
|
|
✓ |
|
Vietnamese |
| A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Déjérine—Sottas syndrome patients |
|
|
|
|
|
|
|
|
|
| Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose‐1‐phosphate uridyltransferase (GALT) deficiency |
|
|
|
|
|
|
✓ |
|
Italian patients |
| Crouzon syndrome: Previously unrecognized deletion, duplication, and point mutation within FGFR2 gene |
|
|
|
|
|
|
|
|
|
| Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan |
|
|
|
|
|
|
|
|
|
| Mass allele detection (MAD) of rare 5‐HT1A structural variants with allele‐specific amplification and electrochemiluminescent detection |
|
|
|
|
|
|
|
|
|
| New frameshift mutation in the DAX1 gene in a patient with X‐linked adrenal hypoplasia and hypogonadotropic hypogonadism |
|
|
|
|
|
|
|
|
|
| Identification of two new nonsense mutations Q311X and W326X in Exon 2 of the adrenoleukodystrophy (ALD) gene |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis type I: Identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations |
|
|
|
|
|
|
|
|
|
| A novel splice‐site mutation in the CD40L gene in a patient with X‐linked hyper‐IgM syndrome |
|
|
|
|
|
|
|
|
|
| Splice site mutation causing deletion of exon 21 sequences from the proα2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| A 5‐megabase familial deletion removes the IDS and FMR‐1 genes in a male Hunter patient |
|
|
|
|
|
|
|
|
|
| A novel missense mutation in the exon containing the putative ornithine‐binding domain of the OTC enzyme in a female |
|
|
|
|
|
|
|
|
|
| Mutation in the carboxy‐terminal propeptide of the proα1 (I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): Possible implications for protein folding |
|
|
|
|
|
|
|
|
|
| Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B‐100 |
|
|
|
|
|
|
|
|
|
| Identification of three novel mutations in the cystic fibrosis transmembrane conductance regulator gene in Argentinian CF patients |
|
|
|
|
|
|
|
|
|
| Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome |
|
|
|
|
|
|
|
|
|
| Charcot‐Marie‐Tooth type 1B neuropathy: A mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0 |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis IVA (Morquio A): Three novel small deletions in the N‐acetylgalactosamine‐6‐sulfate sulfatase gene |
|
|
|
|
|
|
|
|
|
| Ethnic difference in the pattern of K‐ras oncogene mutations in human colorectal cancers |
|
|
|
|
|
|
|
|
|
| A novel deletion/inversion mutation in the low‐density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| A 3‐base pair in‐frame deletion in exon 8 (delGlu272/273) of the ornithine transcarbamylase gene in late‐onset hyperammonemic coma |
|
|
|
|
|
|
|
|
|
| Three novel APC gene mutations in portuguese FAP kindreds |
|
|
|
|
|
|
|
|
|
| An additional mitochondrial tRNAIle point mutation (A‐to‐G at nucleotide 4295) causing hypertrophic cardiomyopathy |
|
|
|
|
|
|
|
|
|
| Mutations and polymorphisms in the human peripherin‐RDS gene and their involvement in inherited retinal degeneration |
|
|
|
|
|
|
|
|
|
| A novel combination of mitochondrial tRNA and ND1 gene mutations in a syndrome with MELAS, cardiomyopathy, and diabetes mellitus |
|
|
|
|
|
|
|
|
|
| Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases |
|
|
|
|
|
|
|
|
|
| A novel G499D substitution in the α1(III) chain of type III collagen produces variable forms of Ehlers‐Danlos syndrome type IV |
|
|
|
|
|
|
|
|
|
| Characterization of a partial pseudogene homologous to the adrenoleukodystrophy gene and application to mutation detection |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of n‐acetylgalactosamine‐6‐sulfate sulfatase gene in a classical Morquio disease |
|
|
|
|
|
|
|
|
|
| Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African‐Americans |
|
|
|
|
|
|
|
|
|
| Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto‐oncogene mutations |
|
|
|
|
|
|
|
|
|
| Recurrence of the PROC gene mutation R178Q: Independent origins in Spanish protein C deficiency patients |
|
|
|
|
|
|
|
|
|
| New mutation in the 3′‐acceptor splice site of intron 4 in the rhodopsin gene associated with autosomal dominant retinitis pigmentosa in a Basque family |
|
|
|
|
|
|
✓ |
|
Basque |
| Allele‐specific measurement of low‐density lipoprotein receptor transcript levels |
|
|
|
|
|
|
|
|
|
| Ornithine transcarbamylase deficiency: Characterization of gene mutations and polymorphisms |
|
|
|
|
|
|
|
|
|
| Absence of PMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for charcot‐marie‐tooth disease type 1A |
|
|
|
|
|
|
|
|
|
| A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease |
|
|
|
|
|
|
|
|
|
| A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia |
|
|
|
|
|
|
|
|
|
| A common base change in the promoter region of the human endothelial NO‐synthase (NQS3) gene |
|
|
|
|
|
|
|
|
|
| Mutations in pyruvate kinase |
|
|
|
|
|
|
|
|
|
| A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I |
|
|
|
|
|
|
|
|
|
| Repeat offenders: Simple repeat sequences and complex genetic problems |
|
|
|
|
|
|
|
|
|
| Single base‐pair substitutions in pathology and evolution: Two sides to the same coin |
|
|
|
|
|
|
|
|
|
| Three new mutations of the pyruvate dehydrogenase alpha subunit: A point mutation (M181V), 3 bp deletion (‐R282), and 16 bp insertion/frameshift (K358SVS→TVDQS) |
|
|
|
|
|
|
|
|
|
| Sequence variation in intron of prion protein gene, crucial for complete diagnostic strategies |
|
|
|
|
|
|
|
|
|
| A sensitive mutation screening strategy for Fabry disease: Detection of nine mutations in the α‐galactosidase A gene |
|
|
|
|
|
|
|
|
|
| Complex cystic fibrosis allele R334W‐R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient |
|
|
|
|
|
|
|
|
|
| Two novel apolipoprotein A‐IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity |
|
|
|
|
|
|
|
|
|
| Stop codon in exon 30 (E2069X) of β‐spectrin gene associated with hereditary elliptocytosis in spectrin Nagoya |
|
|
|
|
|
|
|
|
|
| Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot‐Marie‐Tooth disease |
|
|
|
|
|
|
|
|
|
| Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure |
|
|
|
|
|
|
|
|
|
| A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male‐limited precocious puberty |
|
|
|
|
|
|
|
|
|
| Missense mutation A346P in the rhodopsin gene in one family with autosomal dominant retinitis pigmentosa |
|
|
|
|
|
|
|
|
|
| Simple detection of a (Finnish) hereditary tyrosinemia type 1 mutation |
|
|
|
|
|
|
|
|
|
| IDS gene‐pseudogene exchange responsible for an intragenic deletion in a hunter patient |
|
|
|
|
|
|
|
|
|
| Population‐specific screening by mutation analysis for diseases frequent in Ashkenazi Jews |
|
|
|
|
|
|
|
|
|
| Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis |
|
|
|
|
|
|
|
|
|
| A point mutation in codon 3 of connexin‐32 is associated with X‐linked charcot‐marie‐tooth neuropathy |
|
|
|
|
|
|
|
|
|
| Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C‐terminal domain of lipoprotein lipase causes familial chylomicronemia |
|
|
|
|
|
|
|
|
|
| Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers |
|
|
|
|
|
|
|
|
|
| Chimeric probe‐mediated ribonuclease protection assay for molecular diagnosis of mRNA deficiencies |
|
|
|
|
|
|
|
|
|
| Mutation analysis in 20 patients with Hunter disease |
|
|
|
|
|
|
|
|
|
| Molecular genetics of human antithrombin deficiency |
|
|
|
|
|
|
|
|
|
| Substitution of A1498D in noncollagen domain of a5(IV) collagen chain associated with adult‐onset X‐linked alport syndrome |
|
|
|
|
|
|
|
|
|
| Novel initiation codon mutation Met1Thr identified in a patient with partial hypoxanthine‐guanine phosphoribosyl‐transferase (HPRT) deficiency: HPRT Heidelberg |
|
|
|
|
|
|
|
|
|
| Identification of two sporadically derived mutations in the Von Hippel‐Lindau gene |
|
|
|
|
|
|
|
|
|
| PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme |
|
|
|
|
|
|
|
|
|
| Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the β‐glucocerebrosidase gene in Gaucher's disease patients |
|
|
|
|
|
|
|
|
|
| Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR |
|
|
|
|
|
|
|
|
|
| DGGE analysis as supplement to SSCP analysis of the phenylalanine hydroxylase gene: Detection of eight (one de novo, seven inherited) of nine remaining Norwegian PKU mutations |
|
|
|
|
|
|
|
|
|
| Somatic stability of the expanded CAG trinucleotide repeat in X‐linked spinal and bulbar muscular atrophy |
|
|
|
|
|
|
|
|
|
| Rapid molecular diagnosis of mutations associated with generalized thyroid hormone resistance by PCR‐coupled automated direct sequencing of genomic DNA: Detection of two novel mutations |
|
|
|
|
|
|
|
|
|
| Mutation analysis of phenylketonuria in South Brazil |
|
|
|
|
|
|
|
|
|
| Unequal homologous crossing over resulting in duplication of 36 base pairs within Exon 47 of the COL4A5 gene in a family with Alport syndrome |
|
|
|
|
|
|
|
|
|
| Type 1 Gaucher disease: Identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese |
|
|
|
|
|
|
✓ |
|
Portuguese |
| Mutation characterization of CFTR gene in 206 Northern Irish CF families: Thirty mutations, including two novel, account for 94% of CF chromosomes |
|
|
|
|
|
|
|
|
|
| A locus‐specific mutation database for the neural cell adhesion molecule L1CAM (Xq28) |
|
|
|
|
|
|
|
|
|
| A novel mutation in the BRCA1 gene in a German early‐onset breast cancer family |
|
|
|
|
|
|
|
|
|
| Identification of a novel mutation (A268G) in exon 8 of the HTRβ gene in a large family with thyroid hormone resistance |
|
|
|
|
|
|
|
|
|
| A newly identified aldolase B splicing mutation (G→C, 5′ intron 5) in hereditary fructose intolerance from New Zealand |
|
|
|
|
|
|
|
|
|
| Identification of a mutation in the mitochondrial tRNACys gene associated with mitochondrial encephalopathy |
|
|
|
|
|
|
|
|
|
| Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses |
|
|
|
|
|
|
|
|
|
| Fumarylacetoacetase mutations in tyrosinaemia type I |
|
|
|
|
|
|
|
|
|
| Two point mutations (313 + 1G→A and 313 + 1G→T) in the splice donor site of intron 3 of the low‐density lipoprotein receptor gene are associated with familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Pelizaeus‐Merzbacher disease: A novel mutation in the 5′‐untranslated region of the proteolipid protein gene |
|
|
|
|
|
|
|
|
|
| Identification of a donor splice site mutation leading to loss of p22‐phox exon 5 in autosomal chronic granulomatous disease |
|
|
|
|
|
|
|
|
|
| Three novel and two recurrent mutations of the Norrie disease gene in patients with Norrie syndrome |
|
|
|
|
|
|
|
|
|
| Comprehensive and accurate mutation scanning of the CFTR gene by two‐dimensional DNA electrophoresis |
|
|
|
|
|
|
|
|
|
| Four novel germline mutations of the APC gene |
|
|
|
|
|
|
|
|
|
| Mutation analysis in CD40 ligand deficiency leading to X‐linked hypogammaglobulinemia with hyper IgM syndrome |
|
|
|
|
|
|
|
|
|
| Fluorescent multiplex microsatellites used to define haplotypes associated with 75 CFTR mutations from the UK on 437 CF chromosomes |
|
|
|
|
|
|
|
|
|
| Phenylalanine hydroxylase deficiency in a population in Germany: Mutational profile and nine novel mutations |
|
|
|
|
|
|
|
|
|
| Independent origin of single and double mutations in the human glucose 6‐phosphate dehydrogenase gene |
|
|
|
|
|
|
|
|
|
| A novel mutation in exon 6 (F236S) of the proteolipid protein gene is associated with spastic paraplegia |
|
|
|
|
|
|
|
|
|
| Glucocerebrosidase (Gaucher disease) |
|
|
|
|
|
|
|
|
|
| A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles |
|
|
|
|
|
|
|
|
|
| Mutation detection by solid phase primer extension |
|
|
|
|
|
|
|
|
|
| Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging |
|
|
|
|
|
|
|
|
|
| Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland |
|
|
|
|
|
|
|
|
|
| Mutation nomenclature: Nicknames, systematic names, and unique identifiers |
|
|
|
|
|
|
|
|
|